Key Developments: Kips Bay Medical Inc (KIPS.PK)

KIPS.PK on OTC Markets Group

0.03USD
1:40pm EDT
Change (% chg)

$0.00 (+16.67%)
Prev Close
$0.02
Open
$0.03
Day's High
$0.03
Day's Low
$0.02
Volume
166,750
Avg. Vol
177,974
52-wk High
$0.65
52-wk Low
$0.02

Search Stocks

Latest Key Developments (Source: Significant Developments)

Kips Bay Medical Inc announces $3.25 mln private placement bridge financing
Tuesday, 24 Mar 2015 04:37pm EDT 

Kips Bay Medical Inc:Enters into securities purchase agreement with several investors, including Manny VillafaƱa, Chairman and CEO and Kips Bay Investments, LLC, pursuant to which such investors have agreed to purchase up to $3.25 mln in shares of common stock in four equal tranches.Under terms of securities purchase agreement, first tranche is scheduled to occur as soon as reasonably practicable after it has received ten angiograms from patients enrolled in eMESH I clinical feasibility trial who have had an eSVS Mesh implanted using new surgical implant technique.Says second, third and fourth tranches are scheduled to occur on or about the 90th, 180th and 270th day thereafter.Estimates that first tranche would occur in June or July.Says per share purchase price will be equal to lesser of $0.14 per share and closing sale price of company's common stock on trading day immediately prior to the closing of any tranche.Anticipates that net proceeds, together with its existing cash, cash equivalents and short-term investments, will be sufficient to fund its planned operations through the end of 2016.Says it agreed to use net proceeds from private placement for working capital and general corporate purposes, including primarily funding the process of seeking regulatory approval to market the eSVS Mesh in U.S. and abroad, including continuing human clinical trials.  Full Article

Kips Bay Medical Inc receives updated CE Mark Approval
Monday, 25 Aug 2014 09:00am EDT 

Kips Bay Medical Inc:Announced that it has received an updated CE Mark approving use of new surgical implant technique for its eSVS Mesh.  Full Article

Kips Bay Medical Inc announces FDA approval for U.S. expansion of eMESH I clinical feasibility study
Monday, 17 Mar 2014 07:00am EDT 

Kips Bay Medical Inc:United States Food & Drug Administration (FDA) has granted approval for Kips Bay Medical to include more U.S. patients and U.S. study sites in 'eMESH I' clinical feasibility trial of eSVMesh.Initial approval, FDA indicated that it would allow staged enrollment within United States, starting with 15 patients at up to four sites in the United States.FDA has increased approved number of U.S. patients from 15 to 27 (15 additional from 12 enrolled to date) and increased allowed number of U.S. sites from four to 10.FDA has also approved combination of changes in application of eSVS Mesh to saphenous vein graft and to surgical implant technique for eSVS Mesh treated graft.Changes are intended to reduce the risk of early graft occlusion, make it easier to implant the eSVS Mesh and reduce procedural costs.  Full Article

Kips Bay Medical Inc announces closing of public offering of common stock, including exercise of underwriters' over-allotment option
Wednesday, 29 Jan 2014 11:45am EST 

Kips Bay Medical Inc:Says closing of its underwritten public offering of 5,250,000 shares of common stock and the sale of an additional 785,000 shares of common stock pursuant to the exercise in full by the underwriters of the over-allotment option granted to the underwriters in connection with the offering.Says the gross proceeds to Kips Bay from the offering, including the exercise of the over-allotment option by the underwriters, are $4,224,500.Says it intends to use the net proceeds of this offering for working capital and general corporate purposes.Says Aegis Capital Corp. acted as the sole book-running manager for the offering.  Full Article

Kips Bay Medical Inc announces pricing of public offering of 5,250,000 shares of common stock
Thursday, 23 Jan 2014 08:48pm EST 

Kips Bay Medical Inc:Says the pricing of its previously announced underwritten public offering.Says it is offering 5,250,000 shares of common stock at a public offering price of $0.70 per share for gross proceeds of $3,675,000, prior to deducting the underwriting discount and estimated offering expenses.Says it intends to use the net proceeds of this offering for working capital and general corporate purposes, including funding the process of seeking regulatory approval to market its eSVS Mesh in the United States and abroad, including continuing its human clinical trials.Says it has granted the underwriters a 45-day option to purchase up to an aggregate of 785,000 additional shares of common stock to cover over-allotments, if any.Says the offering is expected to close on or about January 29, 2014.Says Aegis Capital Corp. is acting as the sole book-running manager for the offering.  Full Article

Kips Bay Medical Inc announces proposed public offering of common stock
Thursday, 23 Jan 2014 04:16pm EST 

Kips Bay Medical Inc:Says its intention, subject to market and other conditions, to commence a public offering of its common stock.Says it intends to use the net proceeds of this offering for working capital and general corporate purposes, including funding the process of seeking regulatory approval to market its eSVS Mesh in the United States and abroad, including continuing its human clinical trials.Aegis Capital Corp. is acting as the sole book-running manager for the offering.  Full Article

Search Stocks